Company: STAA
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284603
Chunk: 28

Company: STAAR SURGICAL CO
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 28
---
 and only if: (A) the Board of Directors determines in good faith, after consultation with the Company’s outside legal counsel and financial advisors, that the failure to do so would be inconsistent with the fiduciary duties of the
Board of Directors under applicable Legal Requirements (it being understood that any such determination in and of itself shall not be deemed a Company Adverse Recommendation Change), and (B) the Company shall have given Parent prior written
notice of its intention to make a Company Adverse Recommendation Change or terminate this Agreement pursuant to , which notice shall include the material terms and conditions of the applicable Acquisition
Proposal, an unredacted copy of any such written Acquisition Proposal and the identity of the Person making such Acquisition Proposal, at least four (4) Business Days prior to making any such Company Adverse Recommendation Change or termination
(a “”, and such period, the “”) (which notice shall not constitute a Company Adverse Recommendation Change or termination). Issuance of any “stop, look and listen”
communication by or on behalf of the Company pursuant to Rule 14d-9(f) promulgated under the Exchange Act shall not be considered a Company Adverse Recommendation Change and shall not require the giving of a
Determination Notice or compliance with the procedures set forth in this . The provisions of this shall also apply to any material amendment to any Acquisition Proposal
and shall require a new Determination Notice for each such material amendment; provided, that references to four (4) Business Days shall be deemed to be two (2) Business Days, such that the new Notice Period shall be two
(2) Business Days; and

(ii) other than in connection with an Acquisition Proposal, the Board of Directors may make a
Company Adverse Recommendation Change in response to an Intervening Event, if and only if: (A) the Board of Directors determines in good faith, after consultation with the Company’s outside legal counsel and financial advisors, that the
failure to do so would be inconsistent with the fiduciary duties of the Board of Directors under applicable Legal Requirements (it being understood that any such determination in and of itself shall not be deemed a Company Adverse Recommendation
Change), (B) the Company shall have given Parent a Determination Notice, specifying in reasonable detail the facts and circumstances for such potential Company Adverse Recommendation Change, at least four (4) Business Days prior to making any
such Company Adverse Recommendation Change and, if requested in writing by Parent, during such four (4) Business Day